Designing peptide based hydrogels for 3D-bioprinting applications
Hydrogels have shown significant potential as scaffold of 3D cell culture and tissue engineering applications. In parallel in recent years 3D-bioprinting has become a method of choice for the design and manufacturing of novel biomedical implants or for high through put model cellular printing for drug testing applications. In this project we aim, based on the extensive expertise in the group, to investigate the design of novel peptide/polymer based hydrogels for 3D-bioprinting applications. The project will go all the way from design and formulation of novel materials to its testing in 3D-bioprinting of models and/or implants.
The project is part of the MRC UK Regenerative Medicine Platform (https://www.ukrmp.org.uk/) initiative and is co-sponsored by Manchester BIOGEL (www.manchesterbiogel.com).
We are looking for potential candidate interested in biomaterials and bioprinting as well as in translational medicine work for this highly interdisciplinary project. The work will be done in the Manchester Institute of Biotechnology with collaborators across the University (bioprinting, cancer diagnosis).
Applicants should have at least a 2.1 honours degree in either biomaterials, biomedical engineering, biochemistry, biology, biophysics, biochemistry or similar degrees.
Funded by MRC, The University of Manchester and Manchester BIOGEL. Funding covers tuition fees and annual maintenance payments of £15,009 for eligible UK and EU applicants. We are looking to fill this post as soon as possible.
PhD duration is 3 years. The start date is flexible either September 2019 or January 2020.